Eric Offenberger

Vext Cannabis Co.'s Q2 Revenue Drops Over 8% YoY, But Top Cannabis Analyst Sees Ohio Market As Major Growth Driver

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now

Cannabis Producer Vext Reports YoY Decline In Q1, Announces $2M Standby Credit Facility Ahead Of Ohio Rec Market Launch

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now

Cannabis Producer Vext Reports YoY Decline In Q1, Announces $2M Standby Credit Facility Ahead Of Ohio Rec Market Launch

This Cannabis Co. Expects Significant Growth Once Ohio's Retail Market Launches, Reports Slight YoY Decrease In 2023 Revenue

Tough Q3 For Cannabis Co. Vext Science, But Ohio Rec Market Launch Holds Promise

This Cannabis Co. Expects Significant Growth Once Ohio's Retail Market Launches, Reports Slight YoY Decrease In 2023 Revenue

Tough Q3 For Cannabis Co. Vext Science, But Ohio Rec Market Launch Holds Promise

Cannabis Company Consolidates Arizona Cultivation Footprint After Doubling Down In Ohio

Cannabis Company's Plan To Expand Operations In Ohio, A $10M Private Placement

Eric Offenberger Recent News

Vext Science Q2 Revenue Grows 4.8% YoY, What About Income?

Vext Science, Inc. (OTCQX: VEXTF) (CSE:VEXT) released its financial results for the period ended June 30, 2023, revealing revenue of $9.2 million, an increase of 4.8% compared to $8.8 million in Q2 2022, and an increase of 0.8% compared to $9.1 million in Q1 2023.

Vext Science Q1 Revenue Declines 15.6% YoY, What About Income?

Vext Science, Inc. (OTCQX: VEXTF) (CSE:VEXT) released its financial results for the period ended March 31, 2023, revealing revenue of $9.1 million a decrease of 15.6% compared to $10.8 million in Q1 2022.

Vext Science FY22 Revenue Declines 4.92% To $35.41M, What About Adjusted EBITDA?

Vext Science, Inc. (OTCQX: VEXTF) (CSE: VEXT) FY 2022 revenue was $35.41 million, a decrease of 4.92% compared to $37.24 million in FY 2021. Financial Highlights

Vext Science Revenue Declines 18% YoY, What About Adjusted EBITDA?

Vext Science, Inc. (OTCQX: VEXTF) (CSE:VEXT) revenue in the Q3 2022 was $7.7 million, a decrease of 18% compared to $9.4 million in Q3 2021, and a decrease of 12% compared to 8.8 million in Q2 2022.

Cannabis Company Vext Science Secures $22.2M Credit Facility

Vext Science, Inc.

Vext Science Cannabis Co. Buys 72,000 Sq.Ft. Cultivation Facility In Eloy, Arizona For $4.3M

Cannabis company Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) has purchased a 72,000 square foot vacant cultivation facility in Eloy, Arizona, for $4.3 million in cash.

Arizona Cannabis Brand Vext Science Reports Q1 Positive Adjusted EBITDA Of $3.1M

Cannabis company Vext Science, Inc. (OTCQX: VEXTF) (CSE: VEXT) released its first-quarter unaudited financial results on Wednesday with revenue of $9.16 million, compared to $4.1 million in the same period of 2020.